Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01024231
Brief Title: Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

First Submitted : December 1, 2009
First Submitted that Met QC Criteria : December 1, 2009
First Posted : December 2, 2009 (Estimate)

Results First Submitted : August 28, 2020
Results First Submitted that Met QC Criteria : March 19, 2021
Results First Posted : March 22, 2021

Last Update Submitted that Met QC Criteria : March 19, 2021
Last Update Posted : March 22, 2021